Skip to main content

Florida conference just around the corner

If you live within driving distance of Orlando, and you've ever wanted to know about Hermansky-Pudlak Syndrome, here's your chance. The HPS Network will be in Orlando along with several experts from the National Institutes of Health. HPS testing will be available onsite on a first-come, first-served basis. This is a unique chance for anyone in the albinism community to learn more about HPS and get tested if you like. Don't miss it!

Contact: Elsie Gonzalez, Regional Coordinator, HPS Network Inc. at 407.454.9891 or Debbie Perez at 407.855.3111. Donna Appell, President, HPS Network, (800-789-9477), Hilda Cardona, RN at 301.974.7108

Date: May 21, 2008

FOR IMMEDIATE RELEASE

The Hermansky-Pudlak Syndrome Network sponsors the First Annual Conference for people with HPS/Albinism in Central Florida.

Orlando, Florida – The Puerto-Rican Chamber of Commerce of Central Florida and the Florida Hospital Church are helping the Hermansky-Pudlak Syndrome Network to promote awareness about a rare genetic disorder called Hermansky-Pudlak syndrome (HPS). The syndrome which is relatively common, within the Puerto-Rican community, causes albinism, visual impairment, and a bleeding disorder. Some people with HPS may develop colitis or pulmonary fibrosis (scarring of the lungs).The lung disease is potentially fatal and people with HPS may not be aware they are affected.There are clinical trails available for the treatment of the lung disease at the National Institutes of Health (NIH). Researchers from the National Institutes of Health are teaming up with the HPS Network to promote awareness about HPS among health care professionals and the general public in the Central Florida area. People with albinism and health care professional are invited to the Network conference to learn more about HPS. Attendance is free of charge."It’s our hope that this event will help generate awareness of HPS in the Florida area so that affected families can get the help they need ," said Donna Appell, President of the HPS Network.The conference will be held on Thursday, June 26th. 2008 from 6:00 PM to 10:00 PMAt the Florida Hospital Seventh Day Adventist Church, 2800 North Orange Ave Orlando, and FL 32804.For more information please contact: Elsie Gonzalez, Regional Coordinator, HPS Network Inc. at 407.454.9891, Debbie Perez at 407.855.3111 or Hilda Cardona, RN at 301.974.7108

Comments

Popular posts from this blog

Ratner's Cheesecake

Here's another recipe from Toby! Thanks Toby......and I'll get the others posted soon! Ratner's Cheesecake and plain cookies Ratner's was a Jewish dairy restaurant in the lower East Side of Manhattan. This recipe, from my disintegrating, no longer in print Ratner's cookbook, is the closest I've ever gotten to reproducing the rich, heavy cheesecake my mother made when I was a kid. It's worth the time it takes to prepare and every last calorie. Dough Can be prepared in advance. Makes enough for two cakes. Can be frozen or used to make cookies – see recipe below. 1 cup sugar 1 teaspoon vanilla extract 1 cup shortening 1 teaspoon lemon extract 1 cup butter 2 eggs 3 cups sifted cake flour ½ teaspoon salt 2 cups all purpose flour 1 teaspoon baking powder 1. In a bowl, combine all ingredients with hands. Refrigerate 3 -4 hours, or preferably overnight. Filling (for

The next generation with Hermansky-Pudlak Syndrome

I'm so behind on posting about the trip to Puerto Rico. Since the episode of Mystery Diagnosis on Hermansky-Pudlak Syndrome ran right after we got home, it's been a little busy. These, however, are my favorite pictures from Puerto Rico. I know, not pretty senery etc - but these little guys and gals inspire me. They are the next generation of folks with HPS, and if we keep up the hard work, they will live better lives because of it. They motivate me.

Some good news about Pirfenidone

Below is a press release from Intermune, the company that makes Pirfenidone. They have essentially reviewed the various clinical trials going on, and decided that Pirfenidone is safe and well tolerated. That would pretty much go along with what we've observed in the HPS community as well. We have a few folks that have been on the drug since the late 90s and continue to do well. Of course, as a journalist, I do have to say consider the source - but at the same time, as someone in a Pirfenidone trial, it's good to know. Results of Comprehensive Safety Analysis of pirfenidone In IPF Patients Presented At European Respiratory Meeting - Analysis shows safety and tolerability of pirfenidone across four clinical trials - VIENNA, Sept. 14 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today announced that the results of a comprehensive review of safety data from four clinical studies were presented at the 2009 European Respiratory Society Annual Congress in Vienna, Austria